Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial

IMPORTANCE: Administration of gemcitabine-cisplatin, the current standard therapy for advanced biliary tract cancers, results in median progression-free survival and overall survival of 8.0 and 11.7 months, respectively. New treatments offering improved survival outcomes are therefore needed. OBJECT...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:JAMA Oncol
Main Authors: Shroff, Rachna T., Javle, Milind M., Xiao, Lianchun, Kaseb, Ahmed O., Varadhachary, Gauri R., Wolff, Robert A., Raghav, Kanwal P. S., Iwasaki, Michiko, Masci, Peter, Ramanathan, Ramesh K., Ahn, Daniel H., Bekaii-Saab, Tanios S., Borad, Mitesh J.
Formáid: Artigo
Teanga:Inglês
Foilsithe: American Medical Association 2019
Ábhair:
Original Investigation
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6567834/
https://ncbi.nlm.nih.gov/pubmed/30998813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.0270
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla